Background: B1 transmission-field inhomogeneity has been reported at 3.0 Tesla (T) breast imaging. Enhancement measurements of breast cancers at 3.0T may be insufficient for some patients and improvements in imaging protocols are needed.

Purpose: To quantify B1 inhomogeneities in normal tissue and malignant masses at 3.0T breast MR imaging and to evaluate effect of an imaging protocol using an interleaved sagittal sequence in dynamic contrast-enhanced MRI (DCE-MRI).

Material And Methods: A total of 76 patients were included who underwent DCE-MRI of the breast at 3.0T with an imaging protocol consisting of 1st, 2nd, and 4-6th bilateral axial sequences, and 3rd and 7th unilateral sagittal sequences. Signal intensity (SI) of normal breast tissue was measured at nipple level in four bilateral locations (anterior, posterior, medial, and lateral). Mean whole breast and location specific SI were calculated and compared between right and left breast using a paired t-test. All malignant masses were classified into three groups according to tumor size on MRI (≤2 cm, 2-4 cm, >4 cm). SI of malignant masses was measured independently on axial and sagittal sequences. The axial-sagittal SI gap in each mass was calculated and difference between right and left breast was compared using the t test. Size of each malignant mass was compared with pathologic findings to assess performance of the imaging protocol.

Results: SI of normal breast tissue were lower for the right breast (R-L difference, -91.9; P < 0.0001) and in all four locations (anterior, P < 0.01; posterior, P < 0.01; medial, P < 0.0001; lateral, P < 0.0001). SI of malignant masses were lower for the right breast among same size of the lesions (P < 0.0001), particularly < 4 cm (P < 0.0001). Decreased right to left difference in SI was produced with an interleaved sagittal sequence, as axial-sagittal gap of malignant masses was significant when tumor locates on the right side (P < 0.001). The concordance rate in predicting size of mass in this imaging protocol was 92.2%.

Conclusion: The interleaved sagittal sequence is helpful to adjust reduced SI of malignant masses on right breast at 3.0T. This imaging protocol is clinically applicable by adding a single sequence during DCE-MRI of the breast.

Download full-text PDF

Source
http://dx.doi.org/10.1177/0284185113478006DOI Listing

Publication Analysis

Top Keywords

malignant masses
24
imaging protocol
20
sagittal sequence
16
breast
14
interleaved sagittal
12
imaging
9
dynamic contrast-enhanced
8
axial sequences
8
breast imaging
8
dce-mri breast
8

Similar Publications

Liver masses are common in children, however primary malignant neoplasms are rare, representing only 1% of all pediatric cancers. Hepatocellular neoplasms are the most common primary liver malignancies and hepatoblastoma (HB) is the most frequently diagnosed. The incidence of HB, which is increasing, is approximately of 2 cases per million in the United States, followed by hepatocellular carcinoma (HCC).

View Article and Find Full Text PDF

Gallbladder cancers (GBC) are insidious, malignant, and associated with poor prognosis, with a 5-year survival rate of 5%. Long-term survival in advanced GBC is rare. Here, we report a case of a 45-year-old female who presented with intermittent right upper quadrant pain for 1 month.

View Article and Find Full Text PDF

Rationale: A case of retroperitoneal cystic mature teratoma in an adult male. Retroperitoneal cystic mature teratoma is a type of teratoma. The disease has occult onset, does not have the typical characteristics of teratoma, and is difficult to distinguish from cystadenoma and other diseases.

View Article and Find Full Text PDF

Unmet needs in the management of patients with bilateral synchronous renal masses: the rationale for clinical decision-making.

Minerva Urol Nephrol

December 2024

European Association of Urology (EAU), Young Academic Urologists (YAU) Renal Cancer Working Group, Arnhem, the Netherlands.

Background: Bilateral synchronous renal masses (BSRMs) are a rare finding, and the optimal treatment strategy remains undetermined. This study depicts the management of BSRM at eight European high-volume centers.

Methods: This is a retrospective analysis of prospective institutional databases collecting all patients presenting with clinical T1-2 N0 M0 BSRMs between 1993 and 2020 at 8 tertiary referral high-volume centers for renal cancer treatment in Europe.

View Article and Find Full Text PDF

Ancient schwannoma is a rare benign variant of schwannoma with marked degenerative changes, often mimicking malignancies, particularly when retroperitoneal and pararenal. A 34-year-old woman presented with a rapidly growing 15 cm retroperitoneal pararenal mass. Imaging suggested an aggressive malignancy.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!